Outside of Africa, type 2 diabetes (DM) accounts for as much of the global TB burden as HIV and this fraction is highest in the developing world. Though the strong association between DM and TB has been clearly demonstrated, evidence that DM negatively affects TB clinical outcomes is not as clear, leaving several questions unanswered. The potential causes for potential suboptimal response to treatment among diabetics - low concentrations of anti-TB drugs, poor glycemic control, higher mycobacterial burden at the initiation of therapy, for example - have not been rigorously explored. We will recruit and prospectively follow 600 smear and culture positive TB patients in Rio de Janeiro, Brazil where the DM problem is climbing substantially and a TB epidemic has not subsided.
The specific aims of the study are 1) To estimate the burden of DM and the impact of DM on TB treatment outcomes among patients with smear- positive pulmonary TB in Rio de Janeiro, Brazil, 2) Evaluate the impact of poor diabetic control on response to TB treatment among patients with TB and DM, and, 3) Using pharmacokinetic/pharmaocdynamic (PK/PD) modeling, determine the key contributing factors to poor microbiologic outcomes among patients being treated for pulmonary TB with or without DM. Our multidisciplinary approach will provide the best evidence to date addressing the complex interactions between these two diseases and inform management strategies for developing countries facing these converging epidemics.
With an estimated 285 million people currently living with type 2 diabetes and expectations that this number will climb to over 400 million by 2030, countries in the developing world with already epidemic levels of tuberculosis are at particular risk of suffering the effects of these two converging epidemics. The purpose of this study is to prospectively enroll and follow a cohort of pulmonary tuberculosis patients with and without diabetes in Rio de Janeiro, Brazil in order to measure and compare TB treatment outcomes between these patients. We will address the key contributing factors to poorer treatment responses in patients affected by both diseases.
| Elf, Jessica L; Kinikar, Aarti; Khadse, Sandhya et al. (2018) Secondhand Smoke Exposure and Validity of Self-Report in Low-Income Women and Children in India. Pediatrics 141:S118-S129 |
| Elf, Jessica L; Kinikar, Aarti; Khadse, Sandhya et al. (2018) Sources of household air pollution and their association with fine particulate matter in low-income urban homes in India. J Expo Sci Environ Epidemiol 28:400-410 |
| Gupte, A N; Mave, V; Meshram, S et al. (2018) Trends in HbA1c levels and implications for diabetes screening in tuberculosis cases undergoing treatment in India. Int J Tuberc Lung Dis 22:800-806 |
| Alfarisi, Omamah; Mave, Vidya; Gaikwad, Sanjay et al. (2018) Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment. Antimicrob Agents Chemother 62: |
| Mave, V; Meshram, S; Lokhande, R et al. (2017) Prevalence of dysglycemia and clinical presentation of pulmonary tuberculosis in Western India. Int J Tuberc Lung Dis 21:1280-1287 |
